scholarly article | Q13442814 |
P50 | author | Gerhard Klebe | Q24262166 |
P2093 | author name string | Holger Gohlke | |
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | macromolecule | Q178593 |
P304 | page(s) | 2644-76 | |
P577 | publication date | 2002-08-02 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Angewandte Chemie | Q538683 |
P1476 | title | Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors | |
P478 | volume | 41 |
Q46639902 | (Thermo)dynamic role of receptor flexibility, entropy, and motional correlation in protein-ligand binding |
Q87378606 | A Matter of Order: How E‐Selectin Makes Sweet Contacts |
Q34721619 | A comprehensive examination of the contributions to the binding entropy of protein-ligand complexes |
Q42418169 | A critical assessment of the performance of protein-ligand scoring functions based on NMR chemical shift perturbations. |
Q51543578 | A novel, customizable and optimizable parameter method using spherical harmonics for molecular shape similarity comparisons |
Q45199575 | A spectroscopic and photophysical study on molecular recognition via hydrogen-bonding and pi-pi stacking interactions |
Q36239113 | A unifying review of bioassay-guided fractionation, effect-directed analysis and related techniques. |
Q30386091 | Absolute binding free energy calculations: on the accuracy of computational scoring of protein-ligand interactions |
Q37920386 | Advances and applications of binding affinity prediction methods in drug discovery |
Q47280371 | Alignment-Independent Comparison of Binding Sites Based on DrugScore Potential Fields Encoded by 3D Zernike Descriptors |
Q42238419 | Alpha shapes applied to molecular shape characterization exhibit novel properties compared to established shape descriptors |
Q37409322 | An Evaluation of Explicit Receptor Flexibility in Molecular Docking Using Molecular Dynamics and Torsion Angle Molecular Dynamics |
Q90010732 | An account of solvent accessibility in protein-RNA recognition |
Q33408373 | An effective docking strategy for virtual screening based on multi-objective optimization algorithm |
Q46378945 | An improved method to predict the entropy term with the MM/PBSA approach. |
Q36838120 | An improved relaxed complex scheme for receptor flexibility in computer-aided drug design |
Q37683442 | Analysis of cooperativity by isothermal titration calorimetry |
Q44203281 | Antigen–Antibody Interactions and Structural Flexibility of a Femtomolar-Affinity Antibody |
Q93016939 | Antimalarial Properties of Isoquinoline Derivative from Streptomyces hygroscopicus subsp. Hygroscopicus: An In Silico Approach |
Q50111842 | Application of computational methods for anticancer drug discovery, design, and optimization |
Q30370841 | Application of the 4D fingerprint method with a robust scoring function for scaffold-hopping and drug repurposing strategies. |
Q89217077 | Application of the quantum mechanical IEF/PCM-MST hydrophobic descriptors to selectivity in ligand binding |
Q85323845 | Are Homology Models Sufficiently Good for Free-Energy Simulations? |
Q30835329 | Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. |
Q55037679 | Assessing the stability of free-energy perturbation calculations by performing variations in the method |
Q62582760 | Assessment of Docking Poses: Interactions-Based Accuracy Classification (IBAC) versus Crystal Structure Deviations |
Q29619637 | Benchmarking sets for molecular docking |
Q30392142 | Beyond Membrane Protein Structure: Drug Discovery, Dynamics and Difficulties |
Q35568225 | Binding Affinities of Host–Guest, Protein–Ligand, and Protein–Transition‐State Complexes |
Q56975687 | Binding affinities in the SAMPL3 trypsin and host–guest blind tests estimated with the MM/PBSA and LIE methods |
Q48023567 | Binding affinities of the farnesoid X receptor in the D3R Grand Challenge 2 estimated by free-energy perturbation and docking. |
Q33202843 | Binding affinity prediction with different force fields: examination of the linear interaction energy method |
Q33757755 | Binding affinity prediction with property-encoded shape distribution signatures |
Q37588656 | Binding free energies in the SAMPL5 octa-acid host-guest challenge calculated with DFT-D3 and CCSD(T). |
Q58860073 | Binding free energy calculations and biological testing of novel thiobarbiturates as inhibitors of the human NAD+dependent histone deacetylase Sirt2 |
Q37372747 | Binding of small-molecule ligands to proteins: "what you see" is not always "what you get". |
Q38344912 | Binding selectivity of RecA to a single stranded DNA, a computational approach |
Q37363075 | Binding-affinity predictions of HSP90 in the D3R Grand Challenge 2015 with docking, MM/GBSA, QM/MM, and free-energy simulations |
Q34061956 | Biology-oriented synthesis |
Q36191972 | Biophysical Limits of Protein–Ligand Binding |
Q30044592 | Building a virtual ligand screening pipeline using free software: a survey |
Q35263970 | CSAR benchmark exercise of 2010: combined evaluation across all submitted scoring functions. |
Q45710657 | Calculating binding free energies of host-guest systems using the AMOEBA polarizable force field |
Q51914537 | Calculations of protein-ligand binding entropy of relative and overall molecular motions |
Q47361378 | Can MM/GBSA calculations be sped up by system truncation? |
Q59294029 | Classifying Calpain Inhibitors for the Treatment of Cataracts: A Self Organising Map (SOM) ANN/KM Approach in Drug Discovery |
Q49539854 | Computational and Pharmacological Evaluation of Ferrocene-Based Acyl Ureas and Homoleptic Cadmium Carboxylate Derivatives for Anti-diabetic Potential. |
Q30398071 | Computational methods in drug discovery. |
Q37335295 | Computations of standard binding free energies with molecular dynamics simulations |
Q38916780 | Computer-aided discovery of anti-HIV agents |
Q61813251 | Conserved Disease Modules Extracted From Multilayer Heterogeneous Disease and Gene Networks for Understanding Disease Mechanisms and Predicting Disease Treatments |
Q34145063 | Constraining binding hot spots: NMR and molecular dynamics simulations provide a structural explanation for enthalpy-entropy compensation in SH2-ligand binding |
Q37357274 | Converging ligand-binding free energies obtained with free-energy perturbations at the quantum mechanical level. |
Q39900683 | Cooperative heparin-mediated oligomerization of fibroblast growth factor-1 (FGF1) precedes recruitment of FGFR2 to ternary complexes. |
Q38112830 | Correlating Structure and Energetics in Protein-Ligand Interactions: Paradigms and Paradoxes |
Q84465569 | Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study |
Q85200609 | Crystal molecular dynamics simulations to speed up MM/PB(GB)SA evaluation of binding free energies of di‐mannose deoxy analogs with P51G‐m4‐Cyanovirin‐N |
Q27641371 | D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety |
Q39726767 | DEKOIS: Demanding Evaluation Kits for Objective in Silico Screening — A Versatile Tool for Benchmarking Docking Programs and Scoring Functions |
Q50493869 | Deciphering the mechanisms of selective inhibition for the tandem BD1/BD2 in the BET-bromodomain family |
Q30350781 | Decoys for docking |
Q56979637 | Designing a ligand for pharmaceutical purposes |
Q37581863 | Development of extracellular signal-regulated kinase inhibitors. |
Q42251037 | Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking |
Q36280727 | Discovery of Novel ROCK1 Inhibitors via Integrated Virtual Screening Strategy and Bioassays |
Q34364227 | Docking and scoring in virtual screening for drug discovery: methods and applications |
Q33527932 | Docking flexible ligands in proteins with a solvent exposure- and distance-dependent dielectric function |
Q34563828 | Docking-Based Virtual Screening of Covalently Binding Ligands: An Orthogonal Lead Discovery Approach |
Q28732341 | Drug design for ever, from hype to hope |
Q34536280 | Drug repositioning by structure-based virtual screening |
Q34571023 | Drugs, their targets and the nature and number of drug targets |
Q41459981 | Dynamics of Hydration Water Plays a Key Role in Determining the Binding Thermodynamics of Protein Complexes |
Q41481809 | EMBM − A New Enzyme Mechanism-Based Method for Rational Design of Chemical Sites of Covalent Inhibitors |
Q30362956 | Effect of explicit water molecules on ligand-binding affinities calculated with the MM/GBSA approach. |
Q37307959 | Efficient drug lead discovery and optimization |
Q34908421 | Emerging methods for ensemble-based virtual screening |
Q38792709 | Empirical Scoring Functions for Affinity Prediction of Protein-ligand Complexes |
Q57492456 | Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges |
Q37439036 | Energetics of displacing water molecules from protein binding sites: consequences for ligand optimization |
Q39505064 | Enhanced accumulation of low-molecular-weight chitosan in kidneys: a study on the influence of N-acetylation of chitosan on the renal targeting. |
Q80988436 | Enhancing the accuracy of virtual screening: molecular dynamics with quantum-refined force fields |
Q91163608 | Estimation of Protein-Ligand Unbinding Kinetics Using Non-Equilibrium Targeted Molecular Dynamics Simulations |
Q41815648 | Evaluation of different virtual screening programs for docking in a charged binding pocket |
Q30358437 | Exhaustive docking and solvated interaction energy scoring: lessons learned from the SAMPL4 challenge. |
Q83133195 | Exhaustive search and solvated interaction energy (SIE) for virtual screening and affinity prediction |
Q56989244 | Exploring the free-energy landscape of carbohydrate–protein complexes: development and validation of scoring functions considering the binding-site topology |
Q35089889 | FADB: a food additive molecular database for in silico screening in food toxicology |
Q27998699 | Fast automated placement of polar hydrogen atoms in protein-ligand complexes |
Q39645443 | Free Energy Calculations on Snake Venom Metalloproteinase BaP1 |
Q87611444 | Free-energy perturbation and quantum mechanical study of SAMPL4 octa-acid host-guest binding energies |
Q34153589 | From laptop to benchtop to bedside: structure-based drug design on protein targets. |
Q35070393 | Functional characterization of ECP-heparin interaction: a novel molecular model |
Q42314941 | General van der Waals potential for common organic molecules |
Q47250694 | HawkRank: a new scoring function for protein-protein docking based on weighted energy terms. |
Q34338992 | Higher throughput calorimetry: opportunities, approaches and challenges |
Q51309493 | How Good Are State-of-the-Art Docking Tools in Predicting Ligand Binding Modes in Protein–Protein Interfaces? |
Q47793987 | How accurate are continuum solvation models for drug-like molecules? |
Q47299688 | How accurate is the description of ligand-protein interactions by a hybrid QM/MM approach? |
Q43630348 | How far can virtual screening take us in drug discovery? |
Q51860628 | How sophisticated should a scoring function be to ensure successful docking, scoring and virtual screening? |
Q57296153 | Hydrophobic alkyl chains substituted to the 8-position of cyclic nucleotides enhance activation of CNG and HCN channels by an intricate enthalpy - entropy compensation |
Q27701726 | Identification of a β1/β2-specific sulfonamide proteasome ligand by crystallographic screening |
Q48321338 | Identification of potential aryl hydrocarbon receptor ligands by virtual screening of industrial chemicals. |
Q36320975 | Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target |
Q85306744 | Impact of protein binding cavity volume (PCV) and ligand volume (LV) in rigid and flexible docking of protein–ligand complexes |
Q40130726 | In Silico Characterization of the Binding Affinity of Dendrimers to Penicillin-Binding Proteins (PBPs): Can PBPs be Potential Targets for Antibacterial Dendrimers? |
Q44970440 | In Silico-Screening Approaches for Lead Generation: Identification of Novel Allosteric Modulators of Human-Erythrocyte Pyruvate Kinase |
Q36840592 | In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling |
Q28540772 | Inhibition of catalase by tea catechins in free and cellular state: a biophysical approach |
Q47763550 | Insight into Crizotinib Resistance Mechanisms Caused by Three Mutations in ALK Tyrosine Kinase using Free Energy Calculation Approaches |
Q53771347 | Insight into drug resistance mechanisms and discovery of potential inhibitors against wild-type and L1196M mutant ALK from FDA-approved drugs |
Q80095175 | Integrated approach using protein and ligand information to analyze selectivity- and affinity-determining features of carbonic anhydrase isozymes |
Q39211734 | Interaction of polyhexamethylene biguanide hydrochloride (PHMB) with phosphatidylcholine containing o/w emulsion and consequences for microbicidal efficacy and cytotoxicity |
Q45022698 | Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases |
Q34018803 | Label-free microfluidic characterization of temperature-dependent biomolecular interactions |
Q36579823 | Ligand binding mode prediction by docking: mdm2/mdmx inhibitors as a case study |
Q34754684 | Ligand migration through hemeprotein cavities: insights from laser flash photolysis and molecular dynamics simulations. |
Q34614404 | Ligand-Induced Protein Mobility in Complexes of Carbonic Anhydrase II and Benzenesulfonamides with Oligoglycine Chains |
Q82599858 | MM/GBSA and LIE estimates of host–guest affinities: dependence on charges and solvation model |
Q27689469 | Methyl, ethyl, propyl, butyl: futile but not for water, as the correlation of structure and thermodynamic signature shows in a congeneric series of thermolysin inhibitors |
Q37055383 | Microfluidics for drug discovery and development: from target selection to product lifecycle management |
Q39289157 | Microscopic Modes and Free Energies for Topoisomerase I-DNA Covalent Complex Binding with Non-campothecin Inhibitors by Molecular Docking and Dynamics Simulations |
Q41682682 | Modeling, molecular docking, probing catalytic binding mode of acetyl-CoA malate synthase G in Brucella melitensis 16M. |
Q35150471 | Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery |
Q35912029 | Molecular Mechanisms of Glutamine Synthetase Mutations that Lead to Clinically Relevant Pathologies |
Q40854828 | Molecular Modeling of Geometries, Charge Distributions, and Binding Energies of Small, Druglike Molecules Containing Nitrogen Heterocycles and Exocyclic Amino Groups in the Gas Phase and in Aqueous Solution |
Q33472678 | Molecular determinants of juvenile hormone action as revealed by 3D QSAR analysis in Drosophila |
Q40374329 | Molecular dynamics and MM/GBSA-integrated protocol probing the correlation between biological activities and binding free energies of HIV-1 TAR RNA inhibitors. |
Q35829041 | Molecular evolution of affinity and flexibility in the immune system |
Q54577952 | Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM–GBSA calculation |
Q39676629 | Molecular simulation methods in drug discovery: a prospective outlook |
Q43244976 | Multiple binding modes for palmitate to barley lipid transfer protein facilitated by the presence of proline 12. |
Q42659257 | One Size Does Not Fit All: The Limits of Structure-Based Models in Drug Discovery |
Q52633245 | Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor. |
Q42182002 | PHOENIX: a scoring function for affinity prediction derived using high-resolution crystal structures and calorimetry measurements |
Q33893098 | Physics-based scoring of protein-ligand interactions: explicit polarizability, quantum mechanics and free energies. |
Q30582334 | Plasticity of hydrogen bond networks regulates mechanochemistry of cell adhesion complexes |
Q34373691 | Polarization Effects for Hydrogen-Bonded Complexes of Substituted Phenols with Water and Chloride Ion |
Q51372865 | Predicting the impact of mutations on the specific activity of Bacillus thermocatenulatus lipase using a combined approach of docking and molecular dynamics |
Q34249481 | Prediction of SAMPL3 host–guest binding affinities: evaluating the accuracy of generalized force-fields |
Q27703161 | Prediction of cyclin-dependent kinase 2 inhibitor potency using the fragment molecular orbital method |
Q30495095 | Prediction of the water content in protein binding sites |
Q83072123 | Prediction of zanamivir efficiency over the possible 2009 influenza A (H1N1) mutants by multiple molecular dynamics simulations and free energy calculations |
Q33209836 | ProPose: a docking engine based on a fully configurable protein-ligand interaction model |
Q35750168 | Probing the Effect of Conformational Constraint on Phosphorylated Ligand Binding to an SH2 Domain Using Polarizable Force Field Simulations |
Q46048965 | Probing the interaction of lysozyme with ciprofloxacin in the presence of different-sized Ag nano-particles by multispectroscopic techniques and isothermal titration calorimetry |
Q90153399 | Proposing the Promiscuous Protein Structures in JNK1 and JNK3 for Virtual Screening in Pursuit of Potential Leads |
Q37384155 | Protein-Ligand Interactions: Thermodynamic Effects Associated with Increasing the Length of an Alkyl Chain |
Q51398366 | Protein–Ligand Binding Free Energies from Exhaustive Docking |
Q27675114 | Protein–Ligand Interactions: Thermodynamic Effects Associated with Increasing Nonpolar Surface Area |
Q27683926 | Protein–ligand interactions: Probing the energetics of a putative cation–π interaction |
Q38124417 | Protonation and pK changes in protein-ligand binding. |
Q37934799 | Putting anion-π interactions into perspective |
Q86001715 | Quantification of the Effect of Conformational Restriction on Supramolecular Effective Molarities |
Q34063684 | Quantification of the effects of ionic strength, viscosity, and hydrophobicity on protein-ligand binding affinity |
Q44234859 | Quantitative insights towards the design of potent deazaxanthine antagonists of adenosine 2B receptors |
Q30381275 | Quantitative prediction of protein-protein binding affinity with a potential of mean force considering volume correction. |
Q55016340 | Quantum Chemical Approaches in Structure-Based Virtual Screening and Lead Optimization. |
Q39675574 | Rapid activity prediction of HIV-1 integrase inhibitors: harnessing docking energetic components for empirical scoring by chemometric and artificial neural network approaches |
Q82039592 | Rapid probe and isolation of bioactive compounds from Dioscorea panthaica using human serum albumin functionalized magnetic nano-particles (HSA-MNPs)-based ligand fishing coupled with electrospray ionization mass spectrometry |
Q97074440 | Recent Developments in Linear Interaction Energy Based Binding Free Energy Calculations |
Q39067502 | Refinement, Reduction, and Replacement of Animal Toxicity Tests by Computational Methods |
Q44109422 | Regulatory mechanism of the light-activable allosteric switch LOV-TAP for the control of DNA binding: a computer simulation study. |
Q33893521 | Relative Binding Enthalpies from Molecular Dynamics Simulations Using a Direct Method |
Q48050957 | Relative Binding Free Energy Calculations Applied to Protein Homology Models |
Q30399241 | Remeasuring HEWL pK(a) values by NMR spectroscopy: methods, analysis, accuracy, and implications for theoretical pK(a) calculations |
Q35156305 | Resolving hot spots in the C-terminal dimerization domain that determine the stability of the molecular chaperone Hsp90 |
Q34867886 | SimG: An Alignment Based Method for Evaluating the Similarity of Small Molecules and Binding Sites |
Q79363830 | Smart drug discovery leveraging innovative technologies and predictive knowledge |
Q56890026 | Solvated Interaction Energy (SIE) for Scoring Protein–Ligand Binding Affinities. 2. Benchmark in the CSAR-2010 Scoring Exercise |
Q27677099 | Specificity of Processing -Glucosidase I Is Guided by the Substrate Conformation: CRYSTALLOGRAPHIC AND IN SILICO STUDIES |
Q35635713 | Statistical potential for modeling and ranking of protein-ligand interactions |
Q41785296 | Strategic Targeting of Multiple Water‐Mediated Interactions: A Concise and Rational Structure‐Based Design Approach to Potent and Selective MMP‐13 Inhibitors |
Q42988079 | Structural Modeling of HCV NS3/4A Serine Protease Drug-Resistance Mutations Using End-Point Continuum Solvation and Side-Chain Flexibility Calculations |
Q35080520 | Structural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2',3'-o-(N-methylanthraniloyl)-inosine 5'-triphosphate. |
Q51661462 | Structure‐based quantitative structure‐activity relationship studies of checkpoint kinase 1 inhibitors |
Q47316545 | Symmetrical Parameterization of Rigid Body Transformations for Biomolecular Structures |
Q41416858 | Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2. |
Q39512241 | Target Flexibility in RNA-Ligand Docking Modeled by Elastic Potential Grids |
Q48570844 | Task-parallel message passing interface implementation of Autodock4 for docking of very large databases of compounds using high-performance super-computers |
Q63360901 | The -glycan structures of the antigenic variants of chlorovirus PBCV-1 major capsid protein help to identify the virus-encoded glycosyltransferases |
Q27012984 | The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities |
Q52857114 | The SQM/COSMO filter: reliable native pose identification based on the quantum-mechanical description of protein-ligand interactions and implicit COSMO solvation |
Q57128379 | The Solvated Interaction Energy Method for Scoring Binding Affinities |
Q57901310 | The importance of solvation in the design of ligands targeting membrane proteins |
Q51599141 | The quest for novel chemical matter and the contribution of computer-aidedde novodesign |
Q57096110 | Theoretical Studies on the Susceptibility of Oseltamivir against Variants of 2009 A/H1N1 Influenza Neuraminidase |
Q27702163 | Thermodynamics of protein-ligand interactions as a reference for computational analysis: how to assess accuracy, reliability and relevance of experimental data |
Q51039120 | Toward quantitative estimates of binding affinities for protein-ligand systems involving large inhibitor compounds: a steered molecular dynamics simulation route |
Q57009165 | Towards an Integrated Description of Hydrogen Bonding and Dehydration: Decreasing False Positives in Virtual Screening with the HYDE Scoring Function |
Q37014096 | Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go. |
Q37696666 | Troubleshooting computational methods in drug discovery |
Q37364377 | Trypsin-ligand binding free energies from explicit and implicit solvent simulations with polarizable potential |
Q33642484 | Trypsin-ligand binding free energy calculation with AMOEBA. |
Q86314270 | Two Distinct Thermal Stabilities of DNA and Enzymatic Activities of DNase I in a Multistep Assembly with Carbazole Ligands: Different Binding Characteristics for Duplex and Quadruplex DNA |
Q58768392 | Unraveling the mechanism of the cadherin-catenin-actin catch bond |
Q46306239 | Virtual Screening Approach of Bacterial Peptide Deformylase Inhibitors Results in New Antibiotics. |
Q33247681 | Virtual ligand screening: strategies, perspectives and limitations |
Q30366496 | Virtual screening: an in silico tool for interlacing the chemical universe with the proteome. |
Q42059670 | Web application for studying the free energy of binding and protonation states of protein-ligand complexes based on HINT. |
Q38059796 | What in silico molecular docking can do for the 'bench-working biologists'. |
Q27656255 | ZINC--a free database of commercially available compounds for virtual screening |
Q44505963 | ZZ made EZ: influence of inhibitor configuration on enzyme selectivity. |
Q47166149 | eTOX ALLIES: an automated pipeLine for linear interaction energy-based simulations. |
Search more.